Global Artificial Heart Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Ventricular Assist Device, Total Artificial Heart, and Heart-Lung Machine.

By Power Source;

Internal Battery and External Battery.

By End User;

Hospitals & Clinics, Specialty Centers, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn848954230 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Artificial Heart Market (USD Million), 2021 - 2031

In the year 2024, the Global Artificial Heart Market was valued at USD 1,714.03 million. The size of this market is expected to increase to USD 4,559.34 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 15.0%.

The global artificial heart market has witnessed remarkable growth in recent years, driven by advancements in medical technology, an increasing prevalence of cardiovascular diseases, and a growing aging population. Artificial hearts, which include both total artificial hearts (TAHs) and ventricular assist devices (VADs), represent a critical intervention for patients with end-stage heart failure who are ineligible for heart transplants or awaiting donor hearts. These devices offer a lifeline by providing mechanical circulatory support, thereby improving survival rates and quality of life for patients suffering from severe cardiac conditions.

The market's expansion is underpinned by several factors, including the rising incidence of heart failure, which affects millions of people globally. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, accounting for approximately 17.9 million deaths each year. This alarming statistic underscores the urgent need for effective treatment options like artificial hearts. Moreover, technological innovations have significantly enhanced the efficacy and safety of these devices. Modern artificial hearts are more durable, biocompatible, and capable of mimicking the natural heart's functions with greater precision. Companies are investing heavily in research and development to introduce next-generation devices that offer improved patient outcomes and fewer complications.

The demographic shift towards an older population also fuels the demand for artificial hearts. As the global population ages, the incidence of age-related cardiovascular diseases rises, leading to a higher number of patients requiring advanced medical interventions. Furthermore, increasing awareness and acceptance of artificial heart technologies among both patients and healthcare providers contribute to market growth. Public and private healthcare systems are gradually recognizing the long-term benefits of these devices, including reduced hospital readmission rates and lower healthcare costs associated with managing chronic heart failure.

Regionally, North America dominates the artificial heart market, owing to its well-established healthcare infrastructure, high healthcare expenditure, and favorable reimbursement policies. The presence of key market players and the availability of cutting-edge medical facilities also play a crucial role in the market's growth in this region. Europe and Asia-Pacific are also significant markets, with the latter experiencing rapid growth due to improving healthcare infrastructure, increasing healthcare investments, and rising awareness about advanced cardiac care solutions.

The global artificial heart market faces several challenges. High costs associated with artificial heart devices and the complex surgical procedures required for their implantation can be significant barriers, particularly in developing regions with limited healthcare budgets. Additionally, the risk of complications such as infections, blood clots, and device malfunctions necessitates ongoing improvements in device design and materials. Regulatory hurdles also play a critical role in shaping the market landscape, as stringent approval processes and varying regulatory standards across different regions can delay the introduction of new products.

The market's potential remains robust due to continuous advancements in technology and a growing body of clinical evidence supporting the efficacy and safety of artificial heart devices. The integration of artificial intelligence and machine learning in device management and patient monitoring is an emerging trend that promises to enhance device performance and patient outcomes further. These technologies enable more precise control and real-time adjustments, improving the overall functionality of artificial hearts and potentially extending their lifespan.

Collaborations between medical device manufacturers, research institutions, and healthcare providers are also pivotal in driving innovation and addressing existing challenges. Such partnerships facilitate the development of next-generation devices and foster the sharing of knowledge and best practices. Additionally, government initiatives and funding programs aimed at advancing cardiovascular research and supporting the development of novel medical technologies are expected to boost the market.

The artificial heart market is poised for significant growth as stakeholders across the healthcare spectrum continue to recognize the life-saving potential of these devices. With ongoing advancements and increased investments, artificial hearts are set to become a standard treatment option for patients with severe heart failure, ultimately transforming the landscape of cardiac care and improving patient lives globally. As the market evolves, it will be crucial to address the existing challenges and ensure that these life-saving technologies are accessible to a broader population, thereby maximizing their impact on global health outcomes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Power Source
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Artificial Heart Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Improved Device Durability

        2. Biocompatibility Enhancements

        3. Increased Research and Development

        4. Healthcare Infrastructure Development

      2. Restraints
        1. Stringent Regulatory Approvals

        2. Varying Regional Regulatory Standards

        3. Limited Accessibility in Developing Regions

        4. Long-term Device Longevity Concerns

      3. Opportunities
        1. Public-Private Partnerships

        2. Biocompatible Materials

        3. AI and Machine Learning Integration

        4. Government Funding and Initiatives

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Artificial Heart Market, By Type, 2021 - 2031 (USD Million)
      1. Ventricular Assist Device
      2. Total Artificial Heart
      3. Heart-Lung Machine
    2. Global Artificial Heart Market, By Power Source, 2021 - 2031 (USD Million)
      1. Internal Battery
      2. External Battery
    3. Global Artificial Heart Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics
      2. Specialty Centers
      3. Others
    4. Global Artificial Heart Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea ASEAN (Association of South East Asian Countries)
        6. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. SynCardia Systems, LLC
      2. BiVACOR Inc.
      3. CARMAT
      4. Cleveland Heart, Inc.
      5. ABIOMED
      6. CryoLife, Inc.
      7. Abbott
      8. Thoratec Corporation
  7. Analyst Views
  8. Future Outlook of the Market